Clinical trial · Observational
Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
NCT01350895CI-TRIAL-00012536completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Experimental Group
- label
- Control Group
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 46 Years
Show eligibility criteria text
Inclusion Criteria: * Reproductive age women with sufficient data Exclusion Criteria: * Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome) * women who had had menarche at less than 3 years of age, Day 3 FSH \> 15, or who were older than 46 * women with inadequate clinical/biochemical records * and women who had had ovarian cysts or ovarian tumors in ultrasonography examination * pregnancy women
References
Publications (0)
Data not yet available
No reference posted for this study.